相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias
Noriyuki Enomoto et al.
THORAX (2022)
Antisynthetase syndrome - much more than just a myopathy
Aleksandra Halina Opinc et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
The chaos of serologic markers in interstitial pneumonia with autoimmune features can be corrected by the laboratory physician
La-He Jearn et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
Toby M. Maher et al.
LANCET RESPIRATORY MEDICINE (2020)
CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis
Nicholas K. Arger et al.
RESPIRATORY MEDICINE (2020)
Serum SP-A and KL-6 levels can predict the improvement and deterioration of patients with interstitial pneumonia with autoimmune features
Jingxian Wang et al.
BMC PULMONARY MEDICINE (2020)
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease
John Odackal et al.
ERJ OPEN RESEARCH (2020)
CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features
Masami Kameda et al.
PLOS ONE (2020)
Does Interstitial Pneumonia With Autoimmune Features Represent a Distinct Class of Patients With Idiopathic Interstitial Pneumonia? No
Justin M. Oldham et al.
CHEST (2019)
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients
Gianluca Sambataro et al.
RESPIRATORY MEDICINE (2019)
Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons
Adelle S. Jee et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis
Nicholas K. Arger et al.
RESPIRATORY MEDICINE (2019)
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
K. R. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease
Jeong Seok Lee et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia
Hideaki Yamakawa et al.
RESPIRATORY INVESTIGATION (2019)
Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia
Mingshan Xue et al.
RESPIRATION (2019)
Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: a population-based study
Jinghong Dai et al.
CLINICAL RHEUMATOLOGY (2018)
Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality
Bryan T. Kelly et al.
RESPIROLOGY (2018)
Diagnostic value of KL-6 in idiopathic interstitial pneumonia
Peiyan Zheng et al.
JOURNAL OF THORACIC DISEASE (2018)
Serum Krebs von den Lungen-6 level as a diagnostic biomarker for interstitial lung disease in Chinese patients
Yang Hu et al.
CLINICAL RESPIRATORY JOURNAL (2017)
Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients
Kais Ahmad et al.
RESPIRATORY MEDICINE (2017)
Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features
Yuhei Ito et al.
BMC PULMONARY MEDICINE (2017)
Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease
Hideaki Yamakawa et al.
JOURNAL OF THORACIC DISEASE (2017)
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study
Toby M. Maher et al.
LANCET RESPIRATORY MEDICINE (2017)
Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study
Katsuhiro Oda et al.
SCIENTIFIC REPORTS (2017)
Characterisation of patients with interstitial pneumonia with autoimmune features
Justin M. Oldham et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Clinical features and natural history of interstitial pneumonia with autoimmune features: A single center experience
Sandra Chartrand et al.
RESPIRATORY MEDICINE (2016)
Clinical Association of Chemokine (C-X-C motif) Ligand 1 (CXCL1) with Interstitial Pneumonia with Autoimmune Features (IPAF)
Minrui Liang et al.
SCIENTIFIC REPORTS (2016)
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab
Ganesh Raghu et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
Aryeh Fischer et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis
Tsukasa Okamoto et al.
RESPIRATORY MEDICINE (2015)
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis
Daryle J. DePianto et al.
THORAX (2015)
C-X-C Motif Chemokine 13 (CXCL13) Is a Prognostic Biomarker of Idiopathic Pulmonary Fibrosis
Louis J. Vuga et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease A Systematic Review
Tiffany A. Winstone et al.
CHEST (2014)
Chemokine receptor CXCR3 ligands in bronchoalveolar lavage fluid: associations with radiological pattern, clinical course, and prognosis in sarcoidosis
Wojciech J. Piotrowski et al.
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE (2014)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
The role of circulating fibrocytes in inflammation and autoimmunity
Carole L. Galligan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases
Atsushi Fujiwara et al.
RESPIROLOGY (2012)
Use of Serum Clara Cell 16-kDa (CC16) Levels as a Potential Indicator of Active Pulmonary Fibrosis in Systemic Sclerosis
Minoru Hasegawa et al.
JOURNAL OF RHEUMATOLOGY (2011)
Idiopathic pulmonary fibrosis
Talmadge E. King et al.
LANCET (2011)
Differential T(H)1/T(H)2 Chemokine Expression in Interstitial Pneumonia
Toyohiro Honda et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2010)
CXCR3, Inflammation, and Autoimmune Diseases
Stephanie Lacotte et al.
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
Serum Surfactant Protein-A Is a Strong Predictor of Early Mortality in Idiopathic Pulmonary Fibrosis
Brent W. Kinder et al.
CHEST (2009)
Surfactant Protein D and KL-6 as Serum Biomarkers of Interstitial Lung Disease in Patients with Scleroderma
Faye N. Hant et al.
JOURNAL OF RHEUMATOLOGY (2009)
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis - a longitudinal study
A. Antonelli et al.
RHEUMATOLOGY (2008)
KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts
S Ohshimo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis
HR Collard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis
I Kobayashi et al.
JOURNAL OF PEDIATRICS (2001)
Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis
H Takahashi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
分享论文
